pharma · Primary Sclerosing Cholangitis (PSC) · No medical condition.
Dr. Falk Pharma
Dr. Falk Pharma GmbH
Dr. Falk Pharma trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Leinenweberstraße 5, Freiburg im Breisgau, Baden-Württemberg 79108, DE HQ
399 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Leinenweberstraße 5, Freiburg im Breisgau, Baden-Württemberg 79108, DE
- Employees
- 399
- Programs
- 11
- Drugs
- 15
- Patents
- 0
Dr. Falk Pharma clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Dr. Falk Pharma programs — each row shows trial ID, program name, phase, status, and indication.
Dr. Falk Pharma trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Dr. Falk Pharma.
Trial registry
-
CTIS ↗ -
CTIS ↗ - 2023-507897-42-00CTIS ↗
BUL-5/ESD
Prevention of oesophageal strictures in adult patients after endoscopic submucosal dissection
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗ -
CTIS ↗ -
CTIS ↗ -
CTIS ↗ - 2024-519359-27-00CTIS ↗
Budenofalk 4 mg Zäpfchen, placebo to test
Acute radiation proctitis symptoms in male patients aged 18 years or older with prostate carcinoma
-
CTIS ↗